Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 347

recruiting
3 983
countries
28
conditions
2 109

10 385 trials match your criteria

Giant cell arteritis

Not yet recruiting

Efficacy of upadacitinib plus short prednisolone tapering in adults with Giant Cell Arteritis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Anaesthesia+2

Not yet recruiting

Study of Lidocaine Gel (drug combination) vs Standard Gel for Pain Relief in Patients Undergoing Double-J Ureteral Stent Placement or Exchange

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Safety, Tolerability and Immunogenicity of RSV prefusion F protein 847a and 847b Vaccine in Children 5‑17 Years at High Risk of RSV Disease

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP A, STABILIZED PREFUSION F PROTEIN 847A

Diffuse large B-cell lymphoma+5

Not yet recruiting

Study of MDX2003 in Adults with Relapsed or Refractory B‑Cell Malignancies

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years

Breast cancer

Not yet recruiting

Effect of linzagolix and bilastine on breast density in premenopausal women at high risk of breast cancer: a phase II trial

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years

Liver transplant+1

Not yet recruiting

Precision Monitoring of Tacrolimus and Mycophenolate Mofetil in Adult Liver Transplant Recipients: Randomized Controlled Trial

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Crohn's disease

Not yet recruiting

Evaluation of Upadacitinib for Reducing Ileal Strictures in Patients with Crohn’s Disease

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years

Long‑term study of Pompe disease in all patients receiving alglucosidase alfa drug combination (miglustat, cipaglucosidase alfa, avalglucosidase alfa)

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Alglucosidase Alfa

Mite allergy

Not yet recruiting

Efficacy and safety of house dust mite allergoid (Dermatophagoides farinae, D. pteronyssinus, aluminium hydroxide) in people with moderate to severe house dust mite allergy

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years

Hypogonadism

Not yet recruiting

Effect of Semaglutide and Testosterone Undecanoate on Body Composition in Obese Men with Functional Hypogonadism: A Randomized 52‑Week Trial

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years

Bladder cancer

Not yet recruiting

Feasibility of Photodynamic Diagnosis Using Intravesical Hexaminolevulinate with Sub‑One‑Hour Instillation in Patients with Primary or Recurrent Papillary Bladder Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Pharmacokinetic study of pembrolizumab and drug combination in patients with non‑small cell lung cancer or head and neck squamous cell carcinoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.